Eptifibatide | CAS 188627-80-7 - Request Quote
Eptifibatide
| SZ CAT No: | SZ-E081001 |
| CAS No | 188627-80-7 |
| Mol.F. | C35H49N11O9S2 |
| Mol.Wt. | 832 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Cold Shipment -20°C |
Cold ShipmentChemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Eptifibatide is chemically N6-Amidino-N2-(3-mercaptopropionyl)-l-lysylglycyl-l-α-aspartyl-l-tryptophyl-l-prolyl-l-cysteinamide, cyclic(1-6)-disulfide (as per USP). Eptifibatide is supplied with detailed characterization data compliant with regulatory guideline. Eptifibatide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eptifibatide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 188627-80-7
Purchase 188627-80-7
Order 188627-80-7
Enquire 188627-80-7
price of 188627-80-7
188627-80-7 Supplier
188627-80-7 Manufacturer
188627-80-7 Exporter
buy high quality Eptifibatide
Purchase Eptifibatide
Eptifibatide suppliers
Eptifibatide manufacturers
Eptifibatide price
Order Eptifibatide
Enquire Eptifibatide
Eptifibatide cost
Eptifibatide Supplier
Eptifibatide Distributor
Eptifibatide for Method Validation
Eptifibatide Reference Standard
Eptifibatide for ANDA Filing
Eptifibatide for Forced Degradation Studies
Eptifibatide Identification Standards
Eptifibatide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.